Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
| Image |  |
|---|---|
| Description | scientific article published on 07 March 2019 |
| Author/s |
author: Stine Brændegaard Winther Per Pfeiffer Jesper Ryg Gabor Liposits |
| Publication date | March 7, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |